Apicidin
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No


Apicidin
Description :
Apicidin (OSI 2040) is a fungal metabolite, acts as an orally active histone deacetylase 7/8 (HDAC7/8) inhibitor, with antiparasitic activity and a broad spectrum antiproliferative activity. Apicidin can be used for cancer research[1][2][3][4].Product Name Alternative :
OSI 2040UNSPSC :
12352005Hazard Statement :
H300, H310, H330Target :
HDAC; ParasiteType :
Natural ProductsRelated Pathways :
Anti-infection; Cell Cycle/DNA Damage; EpigeneticsApplications :
Cancer-programmed cell deathField of Research :
Cancer; InfectionAssay Protocol :
https://www.medchemexpress.com/apicidin.htmlPurity :
99.87Solubility :
DMSO : 25 mg/mL (ultrasonic; warming; heat to 60°C)Smiles :
O=C(NC(C(N1[C@]2([H])CCCC1)=O)[C@@H](C)CC)[C@@H](NC([C@@H](NC2=O)CCCCCC(CC)=O)=O)CC3=CN(OC)C4=C3C=CC=C4Molecular Formula :
C34H49N5O6Molecular Weight :
623.78Precautions :
H300, H310, H330References & Citations :
[1]Han JW, et al. Apicidin, a histone deacetylase inhibitor, inhibits proliferation of tumor cells via induction of p21WAF1/Cip1 and gelsolin. Cancer Res. 2000 Nov 1;60 (21) :6068-74.|[2]S J Darkin-Rattray, et al. Apicidin: a novel antiprotozoal agent that inhibits parasite histone deacetylase. Proc Natl Acad Sci U S A. 1996 Nov 12;93 (23) :13143-7.|[3]Beom Soo Shin, et al. Quantitative determination of absorption and first-pass metabolism of apicidin, a potent histone deacetylase inhibitor. Drug Metab Dispos. 2014 Jun;42 (6) :974-82.|[4]Ahn MY, et al. HDAC inhibitor apicidin suppresses murine oral squamous cell carcinoma cell growth in vitro and in vivo via inhibiting HDAC8 expression. Oncol Lett. 2018 Nov;16 (5) :6552-6560.Shipping Conditions :
Blue IceStorage Conditions :
-20°C, 3 years (Powder)Scientific Category :
Natural ProductsClinical Information :
No Development ReportedIsoform :
HDAC7; HDAC8CAS Number :
[183506-66-3]

